Aethlon Medical (AEMD) Net Income towards Common Stockholders (2010 - 2026)

Aethlon Medical's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$2.3 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 93.75% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.6 million (up 82.57% YoY) and the FY2026 annual result came in at -$43.8 million, down 0.81% from the prior year.
• Net Income towards Common Stockholders was -$2.3 million for Q1 2026 at Aethlon Medical, down from -$2.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$1.5 million in Q3 2025 and bottomed at -$36.4 million in Q1 2025.
• A 5-year average of -$9.9 million and a median of -$2.9 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 1262.47% — and 2026, when it jumped 93.75%.
• Aethlon Medical's Net Income towards Common Stockholders stood at -$2.8 million in 2022, then dropped by 21.35% to -$3.5 million in 2023, then jumped by 47.15% to -$1.8 million in 2024, then decreased by 13.01% to -$2.1 million in 2025, then dropped by 10.16% to -$2.3 million in 2026.
• Business Quant data shows AEMD's Net Income towards Common Stockholders at -$2.3 million in Q1 2026, -$2.1 million in Q4 2025, and -$1.5 million in Q3 2025.